Advancing Early Lung Cancer Detection:
Meet DELFI at ATS 2025
© 2025 DELFI Diagnostics, Inc. All rights reserved. FirstLook is a trademark of DELFI Diagnostics, Inc. used worldwide.
General Inquiry: clientservices@delfidiagnostics.com
1810 Embarcadero Road, Suite 100
Palo Alto, CA 94303
2809 Boston Street, Suite 503
Baltimore, MD 21224
800-589-2182
Follow us:
About DELFI Diagnostics
DELFI Diagnostics is a pioneering leader in cancer detection and monitoring through fragmentomics. Our technology analyzes unique DNA fragmentation patterns in the bloodstream to help detect cancer earlier and monitor treatment effectiveness with high sensitivity. DELFI's non-invasive liquid biopsy approach aims to improve patient outcomes and accelerate pharmaceutical development through data-driven insights powered by machine learning and genome-wide analysis.
What is FirstLook Lung?
Commercialized in 2023, the FirstLook Lung blood test is designed to be a convenient first step that can be offered to USPSTF screen-eligible patients during a routine medical visit to help identify lung cancer early, when it’s most treatable.
Learn How Leading Pulmonologists Are Using FirstLook Lung to Enhance Cancer Screening
Sunday, May 18: 10:30 am - 3:30 pm
Monday, May 19: 10:30 am - 3:30 pm
Tuesday, May 20: 10:30 am - 3:30 pm
Elevate Your Physician Narrative with a New Bio!
Booth Information
Ali H. Zaidi, MD
Medical Director of Aerodigestive Research at Allegheny Singer Research Institute
"Whether it's due to lack of awareness that screening is available or reluctance to undergo CT scanning, there are millions of Americans who should be getting screened for lung cancer each year who aren't. The FirstLook blood test may help us better identify those who are most at risk of this disease and who would benefit from follow-up CT screening."
Stop by the DELFI booth to learn expert AI prompting techniques for developing physician profiles to showcase your clinical expertise and authentically connect with patients.
Stand out in a digital landscape where patients make decisions in seconds.
Brittney Storm Rankin
Allegheny Health Network
Visit Booth #1062 to discover how leading health systems are transforming lung cancer screening with a next-generation liquid biopsy test: FirstLook Lung.